Zhen Xing Selected Research

Zhen Xing Research Topics

Disease

23	Neoplasms (Cancer) 04/2022 - 10/2010
4	Breast Neoplasms (Breast Cancer) 01/2018 - 11/2014
3	Glioma (Gliomas) 10/2022 - 12/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2019
2	Carcinogenesis 01/2022 - 10/2010
2	Muscular Dystrophies (Muscular Dystrophy) 01/2021 - 11/2020
2	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2014
1	Ischemic Stroke 12/2022
1	Necrosis 11/2022
1	Liver Diseases (Liver Disease) 11/2022
1	Pleomorphic Adenoma 04/2022
1	Infections 03/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Ischemia 01/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Myocardial Infarction 01/2022
1	Tongue Neoplasms (Tongue Neoplasm) 03/2021
1	Diarrhea 01/2021
1	Contracture 01/2021
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021
1	Obesity 01/2021
1	Hypopigmentation (Hypomelanosis) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 11/2020
1	Ataxia (Dyssynergia) 10/2020
1	Osteosarcoma (Osteogenic Sarcoma) 05/2020
1	Meningioma (Meningiomas) 02/2020
1	Glioblastoma (Glioblastoma Multiforme) 12/2019
1	Heart Arrest (Cardiac Arrest) 06/2019
1	Cardiogenic Shock 06/2019

Drug/Important Bio-Agent (IBA)

8	Long Noncoding RNAIBA 01/2021 - 11/2014
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2010
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2022 - 06/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2010
3	Pharmaceutical PreparationsIBA 01/2021 - 07/2019
3	Small Interfering RNA (siRNA)IBA 10/2016 - 06/2011
2	DystrophinIBA 01/2021 - 11/2020
2	ChemokinesIBA 11/2014 - 04/2013
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	Epidermal Growth Factor (EGF)IBA 11/2022
1	N-oxydiethylene-2-benzothiazole sulfenamide (MMBT)FDA Link 04/2022
1	Dextrans (Dextran)FDA Link 03/2022
1	Chimeric Antigen ReceptorsIBA 03/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	SmokeIBA 01/2022
1	5'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA 01/2022
1	Vasopressins (Vasopressin)IBA 01/2022
1	DioxygenasesIBA 01/2022
1	Dexmedetomidine FDA Link 01/2022
1	PeroxidasinIBA 01/2022
1	VimentinIBA 01/2022
1	S100 Proteins (S 100 Protein)IBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	CarcinogensIBA 01/2022
1	Particulate MatterIBA 01/2022
1	SmectiteIBA 01/2021
1	ferric oxide (iron oxide)IBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	LeptinIBA 01/2021
1	MineralsIBA 01/2021
1	Toll-Like Receptor 2IBA 01/2021
1	OligonucleotidesIBA 01/2021
1	AgrinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	ClayIBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	H19 long non-coding RNAIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2020
1	N- (4- ((6,7- dimethoxy- 4- quinolyl)oxy)- 2- methoxyphenyl)- N'- (1- (1,3- thiazole- 2- yl)ethyl)ureaIBA 10/2020
1	Minocycline (Cyclops)FDA LinkGeneric 10/2020
1	bindaritIBA 10/2020
1	Macrophage Colony-Stimulating FactorIBA 10/2020
1	FlavonoidsIBA 05/2020
1	wogoninIBA 05/2020
1	N-acetoacetyl-N-deacetylcolchicineIBA 02/2020
1	Gefitinib (Iressa)FDA Link 07/2019
1	Contrast MediaIBA 07/2019
1	molybdenum disulfideIBA 07/2019
1	Hyaluronic Acid (Hyaluronan)IBA 07/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 07/2019
1	Pentetic Acid (DTPA)FDA LinkGeneric 07/2019
1	GadoliniumIBA 07/2019

Therapy/Procedure

7	Therapeutics 12/2022 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2016
1	Tissue Transplantation 11/2022
1	Fluid Therapy (Oral Rehydration Therapy) 01/2022
1	One-Lung Ventilation 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022
1	Free Tissue Flaps 03/2021
1	Immunotherapy 01/2021
1	Oral Administration 01/2021
1	Precision Medicine 07/2019
1	Photothermal Therapy 07/2019
1	Extracorporeal Membrane Oxygenation 06/2019